Rx (Prescription Medicine)
USD $ 120.00
Hersima 150mg注射液是一种靶向疗法，用于治疗某些类型的癌症。其活性成分Trastuzumab是一种单克隆抗体，可特异性结合HER2蛋白，而HER2蛋白在部分癌细胞中过度表达。通过结合HER2，Hersima可抑制这些癌细胞的生长与增殖。它适用于HER2阳性乳腺癌以及HER2阳性转移性胃癌或胃食管交界部腺癌的治疗。Hersima 150mg注射液的给药剂量和使用方式应由合格的医疗专业人员根据患者的病情及对治疗的反应来决定。常见的不良反应可能包括发热、寒战、恶心、呕吐、腹泻和疲劳。较少见但严重的不良反应也可能发生，因此如有任何疑虑，请务必与医生讨论。Hersima 150mg注射液应储存在2°C至8°C之间，并避光保存。禁止冷冻。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Trastuzumab 150 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
